https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
An understanding of the biochemistry of the giant cell tumour of bone (GCT provides an opportunity for the development of prognostic markers and identification of therapeutic targets. Based on metabolomic analysis, we proposed glycerophospholipid metabolism as the altered pathway in GCTB and the objective of this study was to identify these altered metabolites. Using phosphorus-31 nuclear magnetic resonance spectroscopy (31P-NMR), sphingomyelin was determined as the most dysregulated phospholipid in tissue samples from si
Like
Comment
Share
